Cargando…
Experiences of dental clinical trials management under COVID-19 in China
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the ongoing coronavirus disease 2019 (COVID-19) pandemic. Despite progress in pandemic prevention and control, it has always been a difficult task for China to pursue a 'zero COVID-19' strategy. Given the aeros...
Autores principales: | Wang, Zheng, Chen, Ruiqi, Liu, Zhihong, Liu, Jinjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702616/ https://www.ncbi.nlm.nih.gov/pubmed/36434237 http://dx.doi.org/10.1038/s41415-022-5205-7 |
Ejemplares similares
-
The COVID-19 pandemic and dentistry: the clinical, legal and economic consequences - part 2: consequences of withholding dental care
por: Coulthard, Paul, et al.
Publicado: (2020) -
Beyond the curriculum: the student experience at Newcastle Dental School
por: Jones, Kiran
Publicado: (2023) -
COVID-19: establishing an oral surgery-led urgent dental care hub
por: Shah, Aneesha, et al.
Publicado: (2020) -
The role of the general dental practitioner in the management of the hypodontia patient
por: Rana, Shivani, et al.
Publicado: (2023) -
COVID-19 presents an opportunity for dental teams to become ready for person-centred care
por: Asimakopoulou, Koula, et al.
Publicado: (2021)